Amylyx Pharmaceuticals Etf Market Value
| AMLX Etf | USD 5.27 0.08 1.54% |
| Symbol | Amylyx |
The market value of Amylyx Pharmaceuticals is measured differently than its book value, which is the value of Amylyx that is recorded on the company's balance sheet. Investors also form their own opinion of Amylyx Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Amylyx Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amylyx Pharmaceuticals' market value can be influenced by many factors that don't directly affect Amylyx Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amylyx Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Amylyx Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amylyx Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Amylyx Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Amylyx Pharmaceuticals' etf what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Amylyx Pharmaceuticals.
| 02/29/2024 |
| 11/25/2024 |
If you would invest 0.00 in Amylyx Pharmaceuticals on February 29, 2024 and sell it all today you would earn a total of 0.00 from holding Amylyx Pharmaceuticals or generate 0.0% return on investment in Amylyx Pharmaceuticals over 270 days. Amylyx Pharmaceuticals is related to or competes with Terns Pharmaceuticals, Acumen Pharmaceuticals, Inozyme Pharma, X4 Pharmaceuticals, Day One, Mereo BioPharma, and Hookipa Pharma. Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for... More
Amylyx Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Amylyx Pharmaceuticals' etf current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Amylyx Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 4.91 | |||
| Information Ratio | 0.2404 | |||
| Maximum Drawdown | 33.56 | |||
| Value At Risk | (6.13) | |||
| Potential Upside | 10.06 |
Amylyx Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Amylyx Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Amylyx Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Amylyx Pharmaceuticals historical prices to predict the future Amylyx Pharmaceuticals' volatility.| Risk Adjusted Performance | 0.211 | |||
| Jensen Alpha | 1.32 | |||
| Total Risk Alpha | 0.5816 | |||
| Sortino Ratio | 0.2721 | |||
| Treynor Ratio | 1.26 |
Amylyx Pharmaceuticals Backtested Returns
Amylyx Pharmaceuticals is slightly risky given 3 months investment horizon. Amylyx Pharmaceuticals secures Sharpe Ratio (or Efficiency) of 0.28, which signifies that the etf had a 0.28% return per unit of risk over the last 3 months. We were able to break down and interpolate thirty different technical indicators, which can help you to evaluate if expected returns of 1.58% are justified by taking the suggested risk. Use Amylyx Pharmaceuticals Mean Deviation of 4.24, risk adjusted performance of 0.211, and Downside Deviation of 4.91 to evaluate company specific risk that cannot be diversified away. The etf shows a Beta (market volatility) of 1.16, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Amylyx Pharmaceuticals will likely underperform.
Auto-correlation | -0.29 |
Weak reverse predictability
Amylyx Pharmaceuticals has weak reverse predictability. Overlapping area represents the amount of predictability between Amylyx Pharmaceuticals time series from 29th of February 2024 to 13th of July 2024 and 13th of July 2024 to 25th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Amylyx Pharmaceuticals price movement. The serial correlation of -0.29 indicates that nearly 29.0% of current Amylyx Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.29 | |
| Spearman Rank Test | -0.77 | |
| Residual Average | 0.0 | |
| Price Variance | 2.08 |
Amylyx Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Amylyx Pharmaceuticals etf's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Amylyx Pharmaceuticals' etf expected returns. We can calculate the autocorrelation of Amylyx Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Amylyx Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the etf is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Amylyx Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Amylyx Pharmaceuticals etf is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Amylyx Pharmaceuticals etf is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Amylyx Pharmaceuticals etf over time.
Current vs Lagged Prices |
| Timeline |
Amylyx Pharmaceuticals Lagged Returns
When evaluating Amylyx Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Amylyx Pharmaceuticals etf have on its future price. Amylyx Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Amylyx Pharmaceuticals autocorrelation shows the relationship between Amylyx Pharmaceuticals etf current value and its past values and can show if there is a momentum factor associated with investing in Amylyx Pharmaceuticals.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Amylyx Etf
Amylyx Pharmaceuticals financial ratios help investors to determine whether Amylyx Etf is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Amylyx with respect to the benefits of owning Amylyx Pharmaceuticals security.